{"id":5711,"date":"2016-02-24T09:00:00","date_gmt":"2016-02-24T09:00:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/"},"modified":"2025-05-27T11:59:23","modified_gmt":"2025-05-27T09:59:23","slug":"johan-keurentjes-in-europese-patientadviesraad","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/","title":{"rendered":"Johan Keurentjes in Europese patientadviesraad voor T1D"},"content":{"rendered":"<img loading=\"lazy\" decoding=\"async\" class=\"wp-image-453 size-thumbnail alignright\" src=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/\"Johan Keurentjes\" width=\"150\" height=\"150\" \/>\n\nIn 2014 maakten we bekend dat de Europese Unie onderzoek zou gaan financieren naar Type 1 Diabetes. Een van de voornaamste onderzoeken gaat nu van start en wordt &#8216;INNODIA&#8217; genoemd. Het onderzoek richt zich op het maken en gebruiken van nieuwe tools die bij kunnen dragen aan het beter behandelen, voorkomen en genezen van Type 1 Diabetes.\n\nBestuurslid van Breakthrough T1D Nederland Johan Keurentjes, die zelf Type 1 Diabetes heeft, is benoemd tot een van de pati\u00ebntadviseurs bij dit onderzoek.\n\nHet doel van het onderzoek is om vooruitgang te boeken op het gebied van het voorspellen, voorkomen en beter behandelen van Type 1 Diabetes. Hiervoor zullen nieuwe tools worden ontwikkeld die daaraan bij kunnen dragen, zoals biomarkers en ziektemodellen. Deze zullen eraan bijdragen om Type 1 Diabetes te onderscheiden en te begrijpen op moleculair en celniveau.\n\nHierdoor kan de toekomstige behandeling van pati\u00ebnten met T1D en mensen met een verhoogd risico op T1D worden verbeterd. Dit alles wordt bewerkstelligd door nauwe samenwerking tussen topwetenschappers in heel Europa, ieder met hun eigen kennis op gebieden zoals immunologie, b\u00e8tacelbiologie, biomarker onderzoek en T1D behandelmethoden. Ook de farmaceutische industrie en overheden zullen bij het onderzoek betrokken worden.","protected":false,"raw":""},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184],"tags":[],"class_list":["post-5711","post","type-post","status-publish","format-standard","hentry","category-archief"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Johan Keurentjes in Europese patientadviesraad voor T1D - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Johan Keurentjes in Europese patientadviesraad voor T1D - Breakthrough T1D\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2016-02-24T09:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-27T09:59:23+00:00\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Johan Keurentjes in Europese patientadviesraad voor T1D\",\"datePublished\":\"2016-02-24T09:00:00+00:00\",\"dateModified\":\"2025-05-27T09:59:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/\"},\"wordCount\":8,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/\",\"articleSection\":[\"Archief\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/\",\"name\":\"Johan Keurentjes in Europese patientadviesraad voor T1D - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/\",\"datePublished\":\"2016-02-24T09:00:00+00:00\",\"dateModified\":\"2025-05-27T09:59:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Johan Keurentjes in Europese patientadviesraad voor T1D\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Johan Keurentjes in Europese patientadviesraad voor T1D - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/","og_locale":"nl_NL","og_type":"article","og_title":"Johan Keurentjes in Europese patientadviesraad voor T1D - Breakthrough T1D","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/","og_site_name":"Breakthrough T1D","article_published_time":"2016-02-24T09:00:00+00:00","article_modified_time":"2025-05-27T09:59:23+00:00","author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Johan Keurentjes in Europese patientadviesraad voor T1D","datePublished":"2016-02-24T09:00:00+00:00","dateModified":"2025-05-27T09:59:23+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/"},"wordCount":8,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/","articleSection":["Archief"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/","name":"Johan Keurentjes in Europese patientadviesraad voor T1D - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/#primaryimage"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/","datePublished":"2016-02-24T09:00:00+00:00","dateModified":"2025-05-27T09:59:23+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/johan-keurentjes-in-europese-patientadviesraad\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Johan Keurentjes in Europese patientadviesraad voor T1D"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=5711"}],"version-history":[{"count":2,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5711\/revisions"}],"predecessor-version":[{"id":9983,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5711\/revisions\/9983"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=5711"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=5711"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=5711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}